10-K Filing

ALKERMES PLC. CIK: 1520262 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001564590-19-003060`
Period End Date	20181231
Filing Date	20190215
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	alks-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 60 Cash Flow Statement 97 Stockholders Equity 29 Comprehensive Income 3

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$191.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$266.76M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investmentsshort-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$242.21M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investmentsshort-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$272.53M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$233.59M	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$292.22M	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetNetCurrent`	$8.23M	USD	Point-in-time
Contract assets	`ContractWithCustomerAssetNetCurrent`	-	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	158.18M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	156.06M	shares	Point-in-time
Inventory	`InventoryNet`	$93.28M	USD	Point-in-time
Inventory	`InventoryNet`	$90.20M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$48.48M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	154.01M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.31M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	155.76M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$983.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$808.84M	USD	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	2.05M	shares	Point-in-time
Treasury shares	`TreasuryStockCommonShares`	2.42M	shares	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$284.74M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$309.99M	USD	Point-in-time
INTANGIBLE ASSETS, NET	`FiniteLivedIntangibleAssetsNet`	$256.17M	USD	Point-in-time
INTANGIBLE ASSETS, NET	`FiniteLivedIntangibleAssetsNet`	$191.00M	USD	Point-in-time
INVESTMENTSLONG-TERM	`LongTermInvestments`	$80.74M	USD	Point-in-time
INVESTMENTSLONG-TERM	`LongTermInvestments`	$157.21M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$84.80M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$65.20M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$85.81M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$98.56M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$14.03M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$16.14M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.80B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.83B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$286.17M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$333.76M	USD	Point-in-time
Contract liabilitiesshort-term	`ContractWithCustomerLiabilityCurrent`	$3.17M	USD	Point-in-time
Contract liabilitiesshort-term	`ContractWithCustomerLiabilityCurrent`	$1.96M	USD	Point-in-time
Long-term debtshort-term	`LongTermDebtCurrent`	$2.84M	USD	Point-in-time
Long-term debtshort-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$339.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$291.12M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$278.44M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$276.46M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$19.20M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$27.96M	USD	Point-in-time
CONTRACT LIABILITIESLONG-TERM	`ContractWithCustomerLiabilityNoncurrent`	$5.66M	USD	Point-in-time
CONTRACT LIABILITIESLONG-TERM	`ContractWithCustomerLiabilityNoncurrent`	$9.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$594.42M	USD	Point-in-time
Total liabilities	`Liabilities`	$653.72M	USD	Point-in-time
COMMITMENTS AND CONTINGENT LIABILITIES (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENT LIABILITIES (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at December 31, 2018 and 2017, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at December 31, 2018 and 2017, respectively	`PreferredStockValue`	-	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 158,180,833 and 156,057,632 shares issued; 155,757,344 and 154,009,456 shares outstanding at December 31, 2018 and 2017, respectively	`CommonStockValue`	$1.56M	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 158,180,833 and 156,057,632 shares issued; 155,757,344 and 154,009,456 shares outstanding at December 31, 2018 and 2017, respectively	`CommonStockValue`	$1.58M	USD	Point-in-time
Treasury shares, at cost (2,423,489 and 2,048,176 shares at December 31, 2018 and 2017, respectively)	`TreasuryStockCommonValue`	$89.35M	USD	Point-in-time
Treasury shares, at cost (2,423,489 and 2,048,176 shares at December 31, 2018 and 2017, respectively)	`TreasuryStockCommonValue`	$108.97M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.34B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.47B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.28M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.04B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.19B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.20B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.31B	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$1.17B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$1.80B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$1.83B	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.09B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$745.69M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$903.37M	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$176.42M	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$154.75M	USD	Annual
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsAndServicesSold`	$132.12M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$387.15M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$425.41M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$412.89M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$421.58M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$374.13M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$526.41M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$65.17M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$60.96M	USD	Annual
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$62.06M	USD	Annual
Total expenses	`CostsAndExpenses`	$1.05B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.19B	USD	Annual
Total expenses	`CostsAndExpenses`	$954.36M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-147.90M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-208.66M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-99.13M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$3.75M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$4.65M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$9.24M	USD	Annual
Interest expense	`InterestExpense`	$15.44M	USD	Annual
Interest expense	`InterestExpense`	$14.89M	USD	Annual
Interest expense	`InterestExpense`	$12.01M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$21.60M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$7.90M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-19.60M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.48M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-2.04M	USD	Annual
Other expense, net	`OtherNonoperatingIncomeExpense`	$-9.62M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-27.84M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$4.63M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-5.72M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-143.27M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-214.39M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-126.97M	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$-5.94M	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$12.34M	USD	Annual
INCOME TAX PROVISION (BENEFIT)	`IncomeTaxExpenseBenefit`	$14.67M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-157.94M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-139.31M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-208.44M	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-1.38	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-1.03	USD	Annual
Basic and diluted (in dollars loss per ordinary share)	`EarningsPerShareBasicAndDiluted`	$-0.90	USD	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153.41M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	151.48M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	155.11M	shares	Annual
Net loss	`NetIncomeLoss`	$-139.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-208.44M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.94M	USD	Annual
Holding gain, net of a tax provision (benefit) of $159, $(295) and $237, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$512.00K	USD	Annual
Holding gain, net of a tax provision (benefit) of $159, $(295) and $237, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$522.00K	USD	Annual
Holding gain, net of a tax provision (benefit) of $159, $(295) and $237, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-518.00K	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-207.92M	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-138.80M	USD	Annual
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-158.46M	USD	Annual

Cash Flow Statement 97 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-157.94M	USD	Annual
Net loss	`ProfitLoss`	$-208.44M	USD	Annual
Net loss	`ProfitLoss`	$-139.31M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$94.26M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$103.66M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$98.52M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$83.92M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$105.36M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$94.40M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$10.62M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$7.23M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-9.69M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-19.60M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$21.60M	USD	Annual
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$7.90M	USD	Annual
Impairment of property, plant and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$5.75M	USD	Annual
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	$-2.30M	USD	Annual
Loss on debt refinancing	`GainsLossesOnExtinguishmentOfDebt`	$-2.08M	USD	Annual
Payment made for debt refinancing	`PaymentsOfDebtRestructuringCosts`	$2.25M	USD	Annual
Impairment of investment in Synchronicity Pharma, Inc.	`EquityMethodInvestmentOtherThanTemporaryImpairment`	$10.47M	USD	Annual
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$4.23M	USD	Annual
Other non-cash charges	`OtherNoncashExpense`	$2.94M	USD	Annual
Other non-cash charges	`OtherNoncashExpense`	$3.47M	USD	Annual
Other non-cash charges	`OtherNoncashExpense`	$979.00K	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$35.62M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$58.63M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$42.49M	USD	Annual
Contract assets	`IncreaseDecreaseInContractWithCustomerAsset`	$-880.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$26.38M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$30.19M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$2.67M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$9.51M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$5.99M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$15.01M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$72.66M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$46.74M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$45.87M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-1.45M	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$-649.00K	USD	Annual
Contract liabilities	`IncreaseDecreaseInContractWithCustomerLiability`	$3.25M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$4.59M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$9.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.09M	USD	Annual
Cash flows provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$99.28M	USD	Annual
Cash flows provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-63.80M	USD	Annual
Cash flows provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$19.19M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$43.66M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$69.43M	USD	Annual
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.30M	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$162.00K	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$194.00K	USD	Annual
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$507.00K	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$375.10M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$397.73M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$431.71M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$560.80M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$444.46M	USD	Annual
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$464.49M	USD	Annual
Investment in Synchronicity Pharma, Inc.	`PaymentsToAcquireEquityMethodInvestments`	$15.00M	USD	Annual
Cash flows (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$127.24M	USD	Annual
Cash flows (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.20M	USD	Annual
Cash flows (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-18.36M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$20.88M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$23.52M	USD	Annual
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$20.31M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$19.62M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.43M	USD	Annual
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$13.47M	USD	Annual
Payment made for debt refinancing	`PaymentsOfFinancingCosts`	$65.81M	USD	Annual
Payment made for debt refinancing	`PaymentsOfFinancingCosts`	$743.00K	USD	Annual
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.23M	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$3.43M	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$3.00M	USD	Annual
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$2.13M	USD	Annual
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-58.17M	USD	Annual
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.62M	USD	Annual
Cash flows (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.08M	USD	Annual
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.27M	USD	Annual
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.92M	USD	Annual
NET INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$75.47M	USD	Annual
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$266.76M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$191.30M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTSBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$191.30M	USD	Point-in-time
CASH AND CASH EQUIVALENTSEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$266.76M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$11.14M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$12.53M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$12.46M	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$2.99M	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$754.00K	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	$5.53M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$5.77M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$11.15M	USD	Annual
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$11.72M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$159.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-295.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$237.00K	USD	Annual
BALANCE	`StockholdersEquity`	$1.20B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.21B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.31B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.17B	USD	Point-in-time
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$20.31M	USD	Annual
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$23.52M	USD	Annual
Issuance of ordinary shares under employee stock plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$20.88M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-13.47M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-19.62M	USD	Annual
Receipt of Alkermes' shares for the purchase of stock options or to satisfy minimum tax withholding obligations related to share based awards	`ReceiptOfCompanyStockForPurchaseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue`	$-16.43M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$107.71M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$83.18M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$94.46M	USD	Annual
Excess tax benefit from share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.83M	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit) $159, $(295), and $237 for the years ended December 31, 2018, 2017 and 2016, respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-518.00K	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit) $159, $(295), and $237 for the years ended December 31, 2018, 2017 and 2016, respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$512.00K	USD	Annual
Unrealized gain (loss) on marketable securities, net of tax provision (benefit) $159, $(295), and $237 for the years ended December 31, 2018, 2017 and 2016, respectively	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$521.00K	USD	Annual
Cumulative effect adjustment related to change in accounting for excess tax benefits	`IncomeTaxEffectsAllocatedDirectlyToEquityCumulativeEffectOfChangeInAccountingPrinciple`	$-61.52M	USD	Annual
Cumulative effect adjustment related to the adoption of new accounting standards	`NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification`	$-1.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-139.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-208.44M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.94M	USD	Annual
BALANCE	`StockholdersEquity`	$1.20B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.21B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.31B	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.17B	USD	Point-in-time

Comprehensive Income 3 line items

Line Item	Tag	Value	Unit	Period
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$159.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-295.00K	USD	Annual
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$237.00K	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.